Heterozygous GATA2 mutations manifest as hematologic, infectious, pulmonary, dermatologic, neoplastic, and vascular/lymphatic diseases, but immunodeficiency remains the hallmark feature of GATA2 deficiency. This evidence concerns the gene GATA2 and Immunodeficiency.